HKMPY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (15 Apr 2024 @ 22:33):

Stats
今日成交量	33.00
平均成交量	130.00
市值	5.16B
Last Dividend	$0.500 ( 2023-08-11 )
Next Dividend	$0 ( N/A )
P/E	27.35
ATR14	$0 (0.00%)

Hikma Pharmaceuticals PLC 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Hikma Pharmaceuticals PLC 财务报表

Annual	2023
营收:	$2.88B
毛利润:	$1.39B (48.35 %)
EPS:	$1.720

FY	2023
营收:	$2.88B
毛利润:	$1.39B (48.35 %)
EPS:	$1.720

FY	2022
营收:	$2.52B
毛利润:	$1.24B (49.19 %)
EPS:	$1.680

FY	2021
营收:	$2.55B
毛利润:	$1.30B (50.96 %)
EPS:	$3.57

Financial Reports:

No articles found.

Hikma Pharmaceuticals PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.380 (N/A)	$0 (N/A)	$0.740 (N/A)	$0 (N/A)	$0.500 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Hikma Pharmaceuticals PLC Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.96 - Stable (0.75%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2012-04-18
Last Dividend	$0.500	2023-08-11
Next Dividend	$0	N/A
Payout Date	2023-09-25
Next Payout Date	N/A
# dividends	24	--
Total Paid Out	$8.89	--
Avg. Dividend % Per Year	0.00%	--
Score	3.65	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.96
Div. Directional Score	8.04	--

Next Divdend (Est)
(2024-06-21)

$0.505 Estimate 7.56 %

Dividend Stability

0.30 Poor

Dividend Score

3.65

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
MUEL	Ex Dividend Junior	2023-08-28	Sporadic	0.00%
CNTHP	Ex Dividend Knight	2023-07-07	Quarterly	0.00%
SWRAY	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
HNFSA	Ex Dividend Junior	2023-08-09	Quarterly	0.00%
ATDRY	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%
OSCUF	Ex Dividend Junior	2023-09-28	Annually	0.00%
DQJCF	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
TSGTY	Ex Dividend Knight	2023-06-23	Annually	0.00%
JDVB	Ex Dividend Knight	2023-07-27	Quarterly	0.00%
BMBN	Ex Dividend Knight	2023-06-30	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0662	1.500	8.68	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0405	1.200	8.65	10.00	[0 - 0.3]
returnOnEquityTTM	0.0864	1.500	-0.151	-0.227	[0.1 - 1]
payoutRatioTTM	0.723	-1.000	2.77	-2.77	[0 - 1]
currentRatioTTM	1.568	0.800	7.16	5.73	[1 - 3]
quickRatioTTM	0.890	0.800	9.47	7.58	[0.8 - 2.5]
cashRatioTTM	0.153	1.500	-0.261	-0.391	[0.2 - 2]
debtRatioTTM	0.254	-1.500	5.76	-8.64	[0 - 0.6]
interestCoverageTTM	5.46	1.000	9.09	9.09	[3 - 30]
operatingCashFlowPerShareTTM	4.79	2.00	8.40	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.96	2.00	8.52	10.00	[0 - 20]
debtEquityRatioTTM	0.542	-1.500	7.83	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.459	1.000	5.69	5.69	[0.2 - 0.8]
operatingProfitMarginTTM	0.165	1.000	8.70	8.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.444	1.000	8.64	8.64	[0.2 - 2]
assetTurnoverTTM	0.612	0.800	9.25	7.40	[0.5 - 2]
Total Score				11.11

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	27.06	1.000	7.37	0	[1 - 100]
returnOnEquityTTM	0.0864	2.50	-0.0971	-0.227	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.96	2.00	9.01	10.00	[0 - 30]
dividendYielPercentageTTM	3.05	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.79	2.00	8.40	10.00	[0 - 30]
payoutRatioTTM	0.723	1.500	2.77	-2.77	[0 - 1]
pegRatioTTM	1.954	1.500	0.306	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.185	1.000	7.88	0	[0.1 - 0.5]
Total Score				4.96

Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.